HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Andrew D Goodman Selected Research
Andrew D Goodman Research Topics
Disease
19
Multiple Sclerosis
10/2022 - 05/2003
3
Atrophy
01/2021 - 01/2021
2
Disease Progression
01/2022 - 07/2014
2
Relapsing-Remitting Multiple Sclerosis
11/2014 - 04/2014
2
Fatigue
10/2003 - 03/2002
1
Ganglion Cysts (Ganglion)
01/2021
1
Bradycardia
12/2019
1
Chronic Disease (Chronic Diseases)
04/2016
1
Pain (Aches)
04/2016
1
Progressive Multifocal Leukoencephalopathy
09/2010
1
Optic Neuritis (Retrobulbar Neuritis)
04/2008
1
Transverse Myelitis (Necrotizing Myelitis)
04/2008
Drug/Important Bio-Agent (IBA)
5
ibudilast
IBA
11/2021 - 10/2016
5
4-Aminopyridine (4 Aminopyridine)
FDA Link
12/2015 - 10/2010
3
Tablets
IBA
12/2015 - 01/2014
2
Amantadine (Aman)
FDA Link
Generic
01/2022 - 03/2002
2
Biomarkers (Surrogate Marker)
IBA
11/2021 - 07/2014
2
Natalizumab (Tysabri)
FDA Link
11/2014 - 09/2010
1
Glatiramer Acetate (Copaxone)
FDA Link
10/2022
1
siponimod
IBA
12/2019
1
Interferon beta-1a
FDA Link
11/2014
1
Neutralizing Antibodies
IBA
04/2014
1
Antibodies
IBA
04/2014
1
Interferons
IBA
04/2014
1
Neurotransmitter Agents (Neurotransmitter)
IBA
01/2013
1
DNA (Deoxyribonucleic Acid)
IBA
09/2010
1
Memantine (Namenda)
FDA Link
02/2010
1
Immunoglobulin G (IgG)
IBA
04/2008
1
Antigens
IBA
05/2003
1
Pemoline (Cylert)
FDA Link
03/2002
Therapy/Procedure
3
Therapeutics
04/2016 - 03/2002
1
Aftercare (After-Treatment)
01/2022
1
Immunomodulation
05/2011
1
Immunotherapy
04/2008